Jonathan G. Drachman

Insider Reports History

Entity
Individual
Location
21823 30 Th Drive Se, Bothell, Washington
Signature
/s/ Frank J. Lanza, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan G. Drachman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Calithera Biosciences, Inc. Director Common Stock 200K $77.2K $0.39 Nov 10, 2021 Direct
Neoleukin Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 350K Aug 2, 2022 Direct
Harpoon Therapeutics, Inc. Director Common Stock 0 Mar 11, 2024 Direct
Harpoon Therapeutics, Inc. Director Director Stock Option (Right to Buy) 0 Mar 11, 2024 Direct

Insider Reports Filed by Jonathan G. Drachman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HARP Harpoon Therapeutics, Inc. Mar 8, 2024 5 $0 4 Mar 11, 2024 Director
HARP Harpoon Therapeutics, Inc. Nov 27, 2023 1 $0 4 Nov 28, 2023 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
NLTX Neoleukin Therapeutics, Inc. Aug 2, 2022 1 $0 4 Aug 4, 2022 President and CEO, Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
NLTX Neoleukin Therapeutics, Inc. Dec 31, 2021 4 $0 5 Feb 14, 2022 President and CEO, Director
CALA Calithera Biosciences, Inc. Nov 10, 2021 1 $172K 4 Nov 10, 2021 Director
NLTX Neoleukin Therapeutics, Inc. Aug 24, 2021 3 $934K 4 Aug 26, 2021 President and CEO, Director
NLTX Neoleukin Therapeutics, Inc. Aug 3, 2021 1 $0 4 Aug 5, 2021 President and CEO, Director
CALA Calithera Biosciences, Inc. Jun 11, 2021 1 $0 4 Jun 14, 2021 Director
NLTX Neoleukin Therapeutics, Inc. Jun 3, 2021 2 $475K 4 Jun 7, 2021 President and CEO, Director
HARP Harpoon Therapeutics, Inc. May 4, 2021 1 $0 4/A May 14, 2021 Director